Toxoplasmosis epidemiology and demographics: Difference between revisions
(Created page with "__NOTOC__ {{Toxoplasmosis}} {{CMG}} ==Overview== ==Epidemiology and Demographics== ==References== {{reflist|2}} {{WikiDoc Help Menu}} {{WikiDoc Sources}} [[Ca...") |
|||
| Line 8: | Line 8: | ||
==Overview== | ==Overview== | ||
Serologic prevalence data indicate that toxoplasmosis is one of the most common of humans infections throughout the world. Infection is more common in warm climates and at lower altitudes than in cold climates and mountainous regions. High prevalence of infection in France has been related to a preference for eating raw or undercooked meat, while high prevalence in Central America has been related to the frequency of stray cats in a climate favoring survival of[[oocyst]]s. The overall seroprevalence in the United States as determined with specimens collected by the third National Health and Nutritional Assessment Survey (NHANES III) between 1988 and 1994 was found to be 22.5%, with seroprevalence among women of childbearing age (15 to 44 years) of 15%. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Revision as of 17:28, 12 December 2012
|
Toxoplasmosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Toxoplasmosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Toxoplasmosis epidemiology and demographics |
|
Risk calculators and risk factors for Toxoplasmosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Serologic prevalence data indicate that toxoplasmosis is one of the most common of humans infections throughout the world. Infection is more common in warm climates and at lower altitudes than in cold climates and mountainous regions. High prevalence of infection in France has been related to a preference for eating raw or undercooked meat, while high prevalence in Central America has been related to the frequency of stray cats in a climate favoring survival ofoocysts. The overall seroprevalence in the United States as determined with specimens collected by the third National Health and Nutritional Assessment Survey (NHANES III) between 1988 and 1994 was found to be 22.5%, with seroprevalence among women of childbearing age (15 to 44 years) of 15%.
Epidemiology and Demographics
References